Last 12 months
Inside the activity.
0 purchase rows · 297 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 21 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 40 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 31 |
| May 2026 | 0 | 38 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 27 |
| Aug 2026 | 0 | 30 |
| Sep 2026 | 0 | 52 |
| Oct 2026 | 0 | 10 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2026 Filed Mar 25, 2026 01:33 UTC |
Mahoney Curtis J.Chief Legal Officer
|
GrantStock Options (right to buy) · Derivative | 7,335 | $0.00 Strike: $1,724.41 | $0.00 |
DisclosureSEC source: 0000950103-26-004599 · dp243962_4-mahoney.xml · derivative · entry 3 Mahoney Curtis J. · CIK 0002105423 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,335 Underlying: Class A Common Stock · 7,335 shares Expires 2031-03-19 F1 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F2 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:33 UTC |
Mahoney Curtis J.Chief Legal Officer
|
GrantStock Options (right to buy) · Derivative | 4,517 | $0.00 Strike: $1,393.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004599 · dp243962_4-mahoney.xml · derivative · entry 2 Mahoney Curtis J. · CIK 0002105423 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,517 Underlying: Class A Common Stock · 4,517 shares Expires 2031-03-19 F1 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F2 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:33 UTC |
Mahoney Curtis J.Chief Legal Officer
|
GrantStock Options (right to buy) · Derivative | 3,202 | $0.00 Strike: $1,116.08 | $0.00 |
DisclosureSEC source: 0000950103-26-004599 · dp243962_4-mahoney.xml · derivative · entry 1 Mahoney Curtis J. · CIK 0002105423 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,202 Underlying: Class A Common Stock · 3,202 shares Expires 2031-03-19 F1 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F2 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 91,239 | $0.00 Strike: $3,727.12 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 8 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,239 Underlying: Class A Common Stock · 91,239 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 249,382 | $0.00 Strike: $3,107.44 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 7 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,382 Underlying: Class A Common Stock · 249,382 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 155,491 | $0.00 Strike: $2,573.06 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 6 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,491 Underlying: Class A Common Stock · 155,491 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 97,541 | $0.00 Strike: $2,114.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 5 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,541 Underlying: Class A Common Stock · 97,541 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 29,340 | $0.00 Strike: $1,724.41 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 4 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,340 Underlying: Class A Common Stock · 29,340 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 18,066 | $0.00 Strike: $1,393.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 3 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,066 Underlying: Class A Common Stock · 18,066 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 12,806 | $0.00 Strike: $1,116.08 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 2 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,806 Underlying: Class A Common Stock · 12,806 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:38 UTC |
Olivan JavierChief Operating Officer
|
GrantRestricted Stock Units (RSU) (Class A) · Derivative | 79,324 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004600 · dp243963_4-olivan.xml · derivative · entry 1 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,324 Underlying: Class A Common Stock · 79,324 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. F2 · derivative.expiration_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 91,239 | $0.00 Strike: $3,727.12 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 8 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,239 Underlying: Class A Common Stock · 91,239 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 249,382 | $0.00 Strike: $3,107.44 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 7 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,382 Underlying: Class A Common Stock · 249,382 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 155,491 | $0.00 Strike: $2,573.06 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 6 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,491 Underlying: Class A Common Stock · 155,491 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 97,541 | $0.00 Strike: $2,114.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 5 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,541 Underlying: Class A Common Stock · 97,541 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 29,340 | $0.00 Strike: $1,724.41 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 4 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,340 Underlying: Class A Common Stock · 29,340 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 18,066 | $0.00 Strike: $1,393.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 3 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,066 Underlying: Class A Common Stock · 18,066 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantStock Options (right to buy) · Derivative | 12,806 | $0.00 Strike: $1,116.08 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 2 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,806 Underlying: Class A Common Stock · 12,806 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:40 UTC |
Cox Christopher KChief Product Officer
|
GrantRestricted Stock Units (RSU) (Class A) · Derivative | 79,324 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004601 · dp243961_4-cox.xml · derivative · entry 1 Cox Christopher K · CIK 0001607459 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,324 Underlying: Class A Common Stock · 79,324 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. F2 · derivative.expiration_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 91,239 | $0.00 Strike: $3,727.12 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 8 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,239 Underlying: Class A Common Stock · 91,239 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 249,382 | $0.00 Strike: $3,107.44 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 7 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,382 Underlying: Class A Common Stock · 249,382 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 155,491 | $0.00 Strike: $2,573.06 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 6 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,491 Underlying: Class A Common Stock · 155,491 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 97,541 | $0.00 Strike: $2,114.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 5 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,541 Underlying: Class A Common Stock · 97,541 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 29,340 | $0.00 Strike: $1,724.41 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 4 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,340 Underlying: Class A Common Stock · 29,340 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 18,066 | $0.00 Strike: $1,393.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 3 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,066 Underlying: Class A Common Stock · 18,066 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantStock Options (right to buy) · Derivative | 12,806 | $0.00 Strike: $1,116.08 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 2 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,806 Underlying: Class A Common Stock · 12,806 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:42 UTC |
Bosworth AndrewChief Technology Officer
|
GrantRestricted Stock Units (RSU) (Class A) · Derivative | 79,324 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004602 · dp243960_4-bosworth.xml · derivative · entry 1 Bosworth Andrew · CIK 0001917373 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,324 Underlying: Class A Common Stock · 79,324 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. F2 · derivative.expiration_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 91,239 | $0.00 Strike: $3,727.12 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 8 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,239 Underlying: Class A Common Stock · 91,239 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 249,382 | $0.00 Strike: $3,107.44 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 7 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,382 Underlying: Class A Common Stock · 249,382 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 155,491 | $0.00 Strike: $2,573.06 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 6 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,491 Underlying: Class A Common Stock · 155,491 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 97,541 | $0.00 Strike: $2,114.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 5 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,541 Underlying: Class A Common Stock · 97,541 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 29,340 | $0.00 Strike: $1,724.41 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 4 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,340 Underlying: Class A Common Stock · 29,340 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 18,066 | $0.00 Strike: $1,393.87 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 3 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,066 Underlying: Class A Common Stock · 18,066 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 12,806 | $0.00 Strike: $1,116.08 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 2 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,806 Underlying: Class A Common Stock · 12,806 shares Expires 2031-03-19 F3 · derivative.exercise_date: The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. F4 · derivative.exercise_date: Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:44 UTC |
LI SUSAN JChief Financial Officer
|
GrantRestricted Stock Units (RSU) (Class A) · Derivative | 43,267 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004603 · dp243933_4-li.xml · derivative · entry 1 LI SUSAN J · CIK 0001739092 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,267 Underlying: Class A Common Stock · 43,267 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. F2 · derivative.expiration_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. Read SEC document |
| March 20, 2026 Filed Mar 25, 2026 01:46 UTC |
Anderson AaronChief Accounting Officer
|
GrantRestricted Stock Units (RSU) (Class A) · Derivative | 5,364 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-004604 · dp243959_4-anderson.xml · derivative · entry 1 Anderson Aaron · CIK 0001645073 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,364 Underlying: Class A Common Stock · 5,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. F2 · derivative.expiration_date: The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:09 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 408 | $632.02 | $257,864.16 |
DisclosureSEC source: 0000950103-26-004334 · dp243608_4-olivan.xml · nonDerivative · entry 5 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan Reinhold Family Revocable Trust u/a/d 10/16/12 Disclosed balance after: 88,453 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F5 · ownership.nature: Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:09 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 82 | $632.02 | $51,825.64 |
DisclosureSEC source: 0000950103-26-004334 · dp243608_4-olivan.xml · nonDerivative · entry 4 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Reinhold D LLC Disclosed balance after: 8,212 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F4 · ownership.nature: Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:09 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 57 | $632.02 | $36,025.14 |
DisclosureSEC source: 0000950103-26-004334 · dp243608_4-olivan.xml · nonDerivative · entry 3 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan Reinhold D LLC Disclosed balance after: 2,714 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F3 · ownership.nature: Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:09 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 82 | $632.02 | $51,825.64 |
DisclosureSEC source: 0000950103-26-004334 · dp243608_4-olivan.xml · nonDerivative · entry 2 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan D LLC Disclosed balance after: 8,212 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F2 · ownership.nature: Shares held of record by the reporting person, manager of Olivan D LLC. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:09 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 926 | $632.02 | $585,250.52 |
DisclosureSEC source: 0000950103-26-004334 · dp243608_4-olivan.xml · nonDerivative · entry 1 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,261 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:14 UTC |
KIMMITT ROBERT MDirector
|
SaleClass A Common Stock | 580 | $632.02 | $366,571.60 |
DisclosureSEC source: 0000950103-26-004335 · dp243607_4-kimmitt.xml · nonDerivative · entry 1 KIMMITT ROBERT M · CIK 0001181218 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,427 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 22:17 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 408 | $634.94 | $259,055.52 |
DisclosureSEC source: 0000950103-26-003623 · dp243045_4-olivan.xml · nonDerivative · entry 5 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan Reinhold Family Revocable Trust u/a/d 10/16/12 Disclosed balance after: 88,861 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F5 · ownership.nature: Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 22:17 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 82 | $634.94 | $52,065.08 |
DisclosureSEC source: 0000950103-26-003623 · dp243045_4-olivan.xml · nonDerivative · entry 4 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Reinhold D LLC Disclosed balance after: 8,294 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F4 · ownership.nature: Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 22:17 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 57 | $634.94 | $36,191.58 |
DisclosureSEC source: 0000950103-26-003623 · dp243045_4-olivan.xml · nonDerivative · entry 3 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan Reinhold D LLC Disclosed balance after: 2,771 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F3 · ownership.nature: Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 22:17 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 82 | $634.94 | $52,065.08 |
DisclosureSEC source: 0000950103-26-003623 · dp243045_4-olivan.xml · nonDerivative · entry 2 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan D LLC Disclosed balance after: 8,294 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F2 · ownership.nature: Shares held of record by the reporting person, manager of Olivan D LLC. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 22:17 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 926 | $634.94 | $587,954.44 |
DisclosureSEC source: 0000950103-26-003623 · dp243045_4-olivan.xml · nonDerivative · entry 1 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,187 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:12 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 408 | $637.21 | $259,981.68 |
DisclosureSEC source: 0000950103-26-003256 · dp242650_4-olivan.xml · nonDerivative · entry 5 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan Reinhold Family Revocable Trust u/a/d 10/16/12 Disclosed balance after: 89,269 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F5 · ownership.nature: Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:12 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 82 | $637.21 | $52,251.22 |
DisclosureSEC source: 0000950103-26-003256 · dp242650_4-olivan.xml · nonDerivative · entry 4 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Reinhold D LLC Disclosed balance after: 8,376 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F4 · ownership.nature: Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:12 UTC |
Olivan JavierChief Operating Officer
|
SaleClass A Common Stock | 57 | $637.21 | $36,320.97 |
DisclosureSEC source: 0000950103-26-003256 · dp242650_4-olivan.xml · nonDerivative · entry 3 Olivan Javier · CIK 0001564475 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Olivan Reinhold D LLC Disclosed balance after: 2,828 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. F3 · ownership.nature: Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.